Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

This study is evaluating a surgical technique — hysteroscopic resection (a minimally invasive procedure through the cervix) — as a fertility-sparing option for women with early uterine (endometrial) cancer or abnormal uterine lining (complex hyperplasia) who wish to preserve their ability to have children. Standard treatment involves removing the uterus, but this approach explores whether surgery combined with hormone therapy can safely manage early disease. **You may be eligible if:** - You have early-stage endometrial cancer or complex uterine hyperplasia (abnormal but pre-cancerous uterine lining) and wish to preserve fertility - You have already completed an adequate course of hormone therapy (typically at least 6 months for cancer cases) - A preliminary evaluation has confirmed you are a suitable candidate for the surgical procedure - The study team has reviewed and approved your case **You may NOT be eligible if:** - Your cancer is at an advanced stage or has features that make fertility-sparing treatment unsafe - You have not completed the required hormone therapy trial - You are not deemed a suitable candidate upon pre-surgical evaluation Talk to your doctor to see if this trial is right for you.